EMA releases its finding on HPV vaccine safety: no link with ‘debilitating illnesses’

The European Medicines Agency (EMA) has completed a thorough review of the safety of the HPV vaccine. No concerns were identified.

Newspaper reports (see our blog piece from June) had suggested a link between the HPV vaccine and ‘debilitating illnesses’ such as POTS (postural orthostatic tachycardia syndrome) and CRPS (Complex Regional Pain Syndrome). But the EMA press release , ahead of the full report which will be published in due course, says that the available scientific evidence “does not support that HPV vaccines cause CRPS or POTS”.

The EMA investigation compared rates of POTS and CRPS in groups vaccinated with HPV and in the general population. In the unvaccinated population, around 150 girls and young women per million aged 10 to 19 years may develop CRPS each year, and at least 150 girls and young women per million may develop POTS each year. The review found no evidence that the overall rates of these syndromes in vaccinated girls were different from expected rates in these age groups, even taking into account possible underreporting. No safety concerns were identified in relation to the HPV vaccine.

UPDATE: Read the full EMA report